<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Real-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+metastatic breast cancer: Turkish oncology group multicenter study

Simple item page
dc.contributor.authorSahin, T.
dc.contributor.authorKemik, F.
dc.contributor.authorMuglu, H.
dc.contributor.authorBiter, S.
dc.contributor.authorTunbekici, S.
dc.contributor.authorOruc, A.
dc.contributor.authorGuren, A.
dc.contributor.authorKaban, K.
dc.contributor.authorAykan, M.
dc.contributor.authorKoylu, B.
dc.contributor.authorEkinci, O.
dc.contributor.authorOnur, I. Deliktas
dc.contributor.authorKalem, A.
dc.contributor.authorAltunok, O.
dc.contributor.authorSeyyar, M.
dc.contributor.authorGuney, B.
dc.contributor.authorAkdogan, O.
dc.contributor.authorYazici, M.
dc.contributor.authorMajidova, N.
dc.contributor.authorEsin, E.
dc.contributor.authorCabuk, D.
dc.contributor.authorYazici, O.
dc.contributor.authorGursu, R.
dc.contributor.authorYilmaz, M.
dc.contributor.authorCinkir, H. Yesil
dc.contributor.authorAtes, O.
dc.contributor.authorCelik, E.
dc.contributor.authorKaradurmus, N.
dc.contributor.authorMandel, N.
dc.contributor.authorBayoglu, I.
dc.contributor.authorAraz, M.
dc.contributor.authorGoker, E.
dc.contributor.authorBayram, E.
dc.contributor.authorErdem, D.
dc.contributor.authorSelcukbiricik, F.
dc.contributor.authorBasaran, G.
dc.contributor.authorSezer, A.
dc.contributor.authorBilici, A.
dc.contributor.authorGunduz, S.
dc.contributor.authorGuven, D.
dc.contributor.authorAksoy, S.
dc.date.accessioned2026-11-05T11:05:02Z
dc.date.issued2026
dc.description.pagesPS50514-PS50514
dc.description.volume32
dc.identifier.doi10.1158/1557-3265.SABCS25-PS5-05-14
dc.identifier.issn1078-0432
dc.identifier.issn1557-3265
dc.identifier.urihttps://doi.org/10.1158/1557-3265.SABCS25-PS5-05-14
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/11261
dc.identifier.wosWOS:001724426403384
dc.identifier.wosWOS:001720220400011
dc.language.isoen
dc.publisherAMER ASSOC CANCER RESEARCH
dc.relation.conferenceSan Antonio Breast Cancer Symposium
dc.relation.hasversion10.1158/1557-3265.SABCS25-PS5-05-14
dc.relation.ispartofCLINICAL CANCER RESEARCH
dc.subjectOncology
dc.titleReal-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+metastatic breast cancer: Turkish oncology group multicenter study
dc.typeMeeting Abstract
oaire.citation.editionScience Citation Index Expanded (SCI-EXPANDED)
oaire.citation.editionConference Proceedings Citation Index - Science (CPCI-S)
oaire.citation.endPagePS50514
oaire.citation.startPagePS50514
oaire.citation.volume32
person.identifier.orcid0000-0002-1053-0668
person.identifier.ridNNG-7452-2025
person.identifier.ridABH-1748-2020
person.identifier.ridOEM-8970-2025
person.identifier.ridHKN-8074-2023
person.identifier.ridGZM-4168-2022
person.identifier.ridKYQ-2189-2024
person.identifier.ridJGU-2420-2023
person.identifier.ridAAX-7648-2020
person.identifier.ridKIH-2771-2024
person.identifier.ridKMA-7131-2024
person.identifier.ridAAD-5588-2021
person.identifier.ridAAY-6154-2020
person.identifier.ridPVC-5130-2026
person.identifier.ridAEK-4253-2022
person.identifier.ridMZR-6469-2025
person.identifier.ridRBQ-6579-2026

Files

Collections

WOS